1 Women's Health Research Institute, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
2 Department of Obstetrics and Gynecology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
J Womens Health (Larchmt). 2019 Jan;28(1):9-16. doi: 10.1089/jwh.2018.7396. Epub 2018 Dec 8.
On January 25th, 2016, the National Institutes of Health (NIH) implemented a policy requiring investigators to consider sex as a biological variable (SABV) within their grant submissions. We surveyed NIH study section members in 2016 and 2017 to determine their attitudes toward the policy and their perceptions regarding its implementation.
Members of standing study sections and special emphasis panels who met in May, June, or July of 2016 and 2017, and had a publicly accessible e-mail address, were invited to participate in the survey (n = 4376 and n = 4710, respectively). The survey assessed participant demographics, knowledge and awareness of the SABV policy, and opinions regarding its utility and implementation.
A combined total of 1161 study section members participated in the survey for a response rate of 10.2% in 2016 and 15.1% in 2017. Respondents thought it was important for NIH-funded research to consider SABV (63% vs. 68%, p = 0.141) and that it will improve rigor and reproducibility (54% vs. 58%, p = 0.208). In terms of implementation, respondents indicated that the percentage of grants, which have successfully addressed and incorporated the policy, has significantly increased over time (p < 0.0001 for all endpoints). However, open-ended comments revealed concern for federal research funding, the overuse of experimental animals, and uncertainty surrounding grant scoring, as it relates to the SABV policy.
In this study, we show improving attitudes toward the sex-inclusive policy at NIH and that a statistically significant number of grants are addressing sex as a biological variable appropriately in their submissions. These data suggest the policy is becoming more well accepted, and it is thus anticipated that the reproducibility of scientific reports will increase over time and new discoveries using sex as a biological variable are on the horizon.
2016 年 1 月 25 日,美国国立卫生研究院(NIH)实施了一项政策,要求研究人员在其资助申请中考虑将性别作为生物变量(SABV)。我们在 2016 年和 2017 年对 NIH 研究分会成员进行了调查,以确定他们对该政策的态度及其对该政策实施的看法。
邀请 2016 年和 2017 年 5 月、6 月或 7 月在常任研究分会和特别重点小组开会且公开提供电子邮件地址的成员参加调查(分别为 n=4376 和 n=4710)。调查评估了参与者的人口统计学特征、对 SABV 政策的了解和认识,以及对其效用和实施的看法。
共有 1161 名研究分会成员参加了调查,2016 年的回复率为 10.2%,2017 年的回复率为 15.1%。受访者认为 NIH 资助的研究考虑 SABV 很重要(63%对 68%,p=0.141),并认为这将提高严谨性和可重复性(54%对 58%,p=0.208)。在实施方面,受访者表示,随着时间的推移,成功解决并纳入该政策的资助数量显著增加(所有终点均 p<0.0001)。然而,开放的评论表明,人们对联邦研究资金、实验动物的过度使用以及与 SABV 政策相关的资助评分的不确定性感到担忧。
在这项研究中,我们表明 NIH 对包含性别的政策的态度正在改善,并且有大量的资助正在其提交中适当解决将性别作为生物变量的问题。这些数据表明该政策越来越被接受,因此预计随着时间的推移,科学报告的可重复性将会提高,并且利用性别作为生物变量的新发现即将出现。